Showing 3371-3380 of 4063 results for "".
- Ripple Therapeutics Appoints Jonathan Talamo, MD, to Chair of the Boardhttps://modernod.com/news/ripple-therapeutics-appoints-jonathan-talamo-md-to-chair-of-the-board/2481265/Ripple Therapeutics announced that Jonathan Talamo, MD, has been appointed as the new Chair of its Board of Directors. Dr. Talamo is internationally known as an experienced surgeon and thought leader in ophthalmology. Following 25 years in clinical practice, Dr. Talamo s
- Kala Pharmaceuticals Submits of Investigational NDA for KPI-012 for the Treatment of Persistent Corneal Epithelial Defecthttps://modernod.com/news/kala-pharmaceuticals-submits-of-investigational-nda-for-kpi-012-for-the-treatment-of-persistent-corneal-epithelial-defect/2481262/Kala Pharmaceuticals announced the submission of an investigational new drug application (NDA) to the FDA for KPI-012 for the treatment of persistent corneal epithelial defect (PCED). Subject to acceptance of the IND by the FDA, Kala remains on-track to initiate a phase 2b cli
- In Final Rule, CMS Rejects Proposal to Make Facility Payments for Office-Based Ophthalmic Surgerieshttps://modernod.com/news/in-final-rule-cms-rejects-proposal-to-make-facility-payments-for-office-based-ophthalmic-surgeries/2481218/In its Medicare Physician Fee Schedule Final Rule for 2023, CMS rejected a proposal to make facility payments for office-based ophthalmic surgeries. The following is a summary of this and other key points in the ruling. Office-based payments. In response to requests to
- Helen Keller Intl and Partners Celebrate Vision Milestone, Screening 1 Million Students in New York Cityhttps://modernod.com/news/helen-keller-intl-and-partners-celebrate-vision-milestone-screening-1-million-students-in-new-york-city/2481208/On October 31, 2022, Helen Keller Intl will reach a major milestone: Its NY Vision team will provide free vision services to its one-millionth New York City student at the Academy for College Preparation and Career Exploration, a community school co-located in the Er
- KYS Vision Reports Clinical Trial Results of Its Remote Physiologic Monitoring System for Patients With Chronic Retinal Conditionshttps://modernod.com/news/kys-vision-reports-clinical-trial-results-of-its-remote-physiologic-monitoring-system-for-patients-with-chronic-retinal-conditions/2481207/KYS Vision announced clinical trial results of its Macustat macular function scan for the remote monitoring of central retinal function. The study was published in the peer-reviewed journal Digital Health1 in October 2022. The study is one
- EyeMed Vision Care Names Matt MacDonald Presidenthttps://modernod.com/news/eyemed-vision-care-names-matt-macdonald-president/2481204/EyeMed has appointed Matt MacDonald to the role of President. Mr. MacDonald succeeds Lukas Ruecker who has decided to step down after 9 years for personal reasons. Mr. MacDonald has been with EyeMed since 2013, and most recently served as Chief Operations Officer. Prior to that, he
- Alcon to Celebrate 75 Years and Showcase Contact Lens Innovations at #Academy22https://modernod.com/news/alcon-to-celebrate-75-years-and-showcase-contact-lens-innovations-at-academy22/2481197/Alcon will feature a host of innovations across its portfolio of products along with pertinent practice takeaways at the American Academy of Optometry Annual Meeting (#Academy22) in San Diego, California, on October 27, 2022. The meeting coincides with Alcon’s Diamond Jubilee, celebrating 7
- Radiance Therapeutics Co-Founders Wendell Lutz, PhD, Honored by the American Society of Radiation Oncology (ASTRO)https://modernod.com/news/radiance-therapeutics-co-founders-wendell-lutz-phd-honored-by-the-american-society-of-radiation-oncology-astro/2481194/Radiance Therapeutics announced that one of its co-founders, Wendell Lutz, PhD, was honored by the American Society of Radiation Oncology (ASTRO) during the Annual Meeting Awards Ceremony in San Antonio on October 25, 2022. According to Radiance, in 1986, Dr. Lutz revolutionized t
- DORC Acquires Peregrine Surgical and Completes Acquisition of the Remaining Stake in WEFIShttps://modernod.com/news/dorc-acquires-peregrine-surgical-and-completes-acquisition-of-the-remaining-stake-in-wefis/2481192/DORC announced the acquisition of Peregrine Surgical and the acquisition of the full ownership of WEFIS GmbH following an initial equity investment announced earlier in 2022. Financial terms of the deals were not disclosed. DORC says both acquisitions extend the productio
- Lenstec Rebrands its Newly Approved Multifocal IOL to ClearView 3https://modernod.com/news/lenstec-rebrands-its-newly-approved-multifocal-iol-to-clearview-3/2481174/Lenstec announced that it has rebranded its new multifocal IOL, the SBL-3, to the ClearView 3 to better describe the vision patients can expect with the new IOL, according to Lenstec. The IOL was approved by the FDA in July 2022. "Since approval, the ClearView